InsidersTradesSigma
Track the AMNEAL PHARMACEUTICALS, INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.3bn. The latest transaction was reported on 13 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: JOHN KIELY. All data is accessible without an account.
Analysts rate AMNEAL PHARMACEUTICALS, INC Strong Buy (bullish), based on 12 analysts. Average price target: US$62.05.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
AMNEAL PHARMACEUTICALS, INC is a pharmaceutical company that specializes in the development and manufacturing of generic and branded medications. It is listed on NASDAQ under the symbol AMRX.